Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

PET imaging in patients with meningioma-report of the RANO/PET Group

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. The natural history of Vestibular Schwannoma growth - prospective 40-year data from an unselected national cohort

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. PET imaging in patients with brain metastasis-report of the RANO/PET group

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Sex-specific gene and pathway modeling of inherited glioma risk

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Prevalence of cognitive impairment and its relation to mental health in Danish lymphoma survivors

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Somatostatin receptor-targeted radiopeptide therapy in treatment-refractory meningioma: Individual Patient Data Meta-analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effect of blood glucose and body weight on image quality in brain [F-18]FDG PET imaging

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  • Norbert Galldiks
  • Nathalie L Albert
  • Michael Sommerauer
  • Anca L Grosu
  • Ute Ganswindt
  • Ian Law
  • Matthias Preusser
  • Emilie Le Rhun
  • Michael A Vogelbaum
  • Gelareh Zadeh
  • Frédéric Dhermain
  • Michael Weller
  • Karl-Josef Langen
  • Jörg C Tonn
Vis graf over relationer

Meningiomas are the most frequent nonglial primary brain tumors and represent about 30% of brain tumors. Usually, diagnosis and treatment planning are based on neuroimaging using mainly MRI or, rarely, CT. Most common treatment options are neurosurgical resection and radiotherapy (eg, radiosurgery, external fractionated radiotherapy). For follow-up after treatment, a structural imaging technique such as MRI or CT is used. However, these structural imaging modalities have limitations, particularly in terms of tumor delineation as well as diagnosis of posttherapeutic reactive changes. Molecular imaging techniques such as PET can characterize specific metabolic and cellular features which may provide clinically relevant information beyond that obtained from structural MR or CT imaging alone. Currently, the use of PET in meningioma patients is steadily increasing. In the present article, we provide recommendations for the use of PET imaging in the clinical management of meningiomas based on evidence generated from studies being validated by histology or clinical course.

OriginalsprogEngelsk
TidsskriftNeuro-Oncology
Vol/bind19
Udgave nummer12
Sider (fra-til)1576-1587
Antal sider12
ISSN1522-8517
DOI
StatusUdgivet - 29 nov. 2017

ID: 52750846